Literature DB >> 25123036

KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.

Dimitra K Alexopoulou1, Christos K Kontos, Spyridon Christodoulou, Iordanis N Papadopoulos, Andreas Scorilas.   

Abstract

BACKGROUND: Dysregulated expression of several KLK family members has been observed in colorectal adenocarcinoma. In the present study, the prognostic value of KLK11 mRNA expression as a molecular tissue biomarker in colorectal adenocarcinoma was examined. MATERIALS &
METHODS: Using quantitative real-time PCR, KLK11 mRNA expression was studied in 120 cancerous and 41 paired noncancerous colorectal specimens obtained from 120 patients with primary colorectal adenocarcinoma.
RESULTS: A significant upregulation of KLK11 transcripts in colorectal tumors was observed. KLK11 mRNA expression was associated with the depth of tumor invasion and the histological grade. Furthermore, KLK11 mRNA expression predicted poor disease-free and overall survival, independently of patient gender, age, tumor size, location, histological subtype, grade, venous invasion, lymphatic invasion, TNM stage, radiotherapy and chemotherapy treatment.
CONCLUSION: KLK11 mRNA expression could be considered as a new molecular prognostic biomarker in colorectal adenocarcinoma, with additional prognostic value in patients with highly invasive tumors and/or positive lymph nodes.

Entities:  

Keywords:  biological tumor markers; colon cancer; kallikreins; prognostic biomarkers; quantitative real-time PCR

Mesh:

Substances:

Year:  2014        PMID: 25123036     DOI: 10.2217/bmm.13.151

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  15 in total

1.  Alternative Splicing Detection Tool-a novel PERL algorithm for sensitive detection of splicing events, based on next-generation sequencing data analysis.

Authors:  Panagiotis G Adamopoulos; Margarita C Theodoropoulou; Andreas Scorilas
Journal:  Ann Transl Med       Date:  2018-06

Review 2.  Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer.

Authors:  Marios A Diamantopoulos; Panagiotis Tsiakanikas; Andreas Scorilas
Journal:  Ann Transl Med       Date:  2018-06

3.  BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis.

Authors:  Rongfang Qiu; Hang Shi; Shuang Wang; Shuai Leng; Ruiqiong Liu; Yu Zheng; Wei Huang; Yi Zeng; Jie Gao; Kai Zhang; Yongqiang Hou; Dandan Feng; Yang Yang
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

4.  Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.

Authors:  Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos
Journal:  Tumour Biol       Date:  2014-01-16

5.  Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis.

Authors:  Aristotelis Kourtis; Panagiotis G Adamopoulos; Apostolos Papalois; Dimitrios C Iliopoulos; George C Babis; Andreas Scorilas
Journal:  Ann Transl Med       Date:  2018-06

6.  Kallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters.

Authors:  Tulin Ozturk; Ecem Zeynep Kain; Mete Bora Tuzuner; Ayca Diren; Sebnem Batur; Hulya Yilmaz-Aydogan; Oguz Ozturk; Turgay Isbir
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

7.  Knockdown of KLK11 inhibits cell proliferation and increases oxaliplatin sensitivity in human colorectal cancer.

Authors:  Zongbin Xu; Pan Chi; Jie Pan; Songfei Shen; Yanwu Sun; Xiaojie Wang; Xingrong Lu
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

8.  Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing.

Authors:  Panagiotis G Adamopoulos; Christos K Kontos; Andreas Scorilas
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

9.  Independent prognostic genes and mechanism investigation for colon cancer.

Authors:  Chunsheng Li; Zhen Shen; Yangyang Zhou; Wei Yu
Journal:  Biol Res       Date:  2018-04-13       Impact factor: 5.612

10.  Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.

Authors:  Ritu Pandey; Muhan Zhou; Yuliang Chen; Dalila Darmoul; Conner C Kisiel; Valentine N Nfonsam; Natalia A Ignatenko
Journal:  Genes (Basel)       Date:  2021-05-16       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.